Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-09
1996-04-09
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514445, 549 62, 549 65, C07D33332, C07D33334, A61K 3138, A61K 31385
Patent
active
055062610
ABSTRACT:
Compounds of the structure ##STR1## wherein Z is selected from optionally substituted thienyl, thiazolyl, oxazolyl and furyl are potent inhibitors of lipoxygenase enzymes and thus inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment or amelioration of allergic and inflammatory disease states.
REFERENCES:
patent: 5169854 (1992-12-01), Brooks et al.
patent: 5288751 (1994-02-01), Brooks et al.
Brooks Dee W.
Craig Richard A.
Stewart Andrew O.
Abbott Laboratories
Janssen Jerry F.
Rotman Alan L.
LandOfFree
Substituted aryl- and heteroarylalkenyl-N-hydroxyurea inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aryl- and heteroarylalkenyl-N-hydroxyurea inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aryl- and heteroarylalkenyl-N-hydroxyurea inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139515